AstraZeneca Trial on Hold Pending U.S. Scrutiny, Reuters Reports

Published September 14, 2020

AstraZeneca Plc’s Covid-19 vaccine trial remains on hold in the U.S. as regulators examine a serious side effect suffered by a U.K. patient, Reuters reported on Monday.